Picture of Biosenic SA logo

BIOS Biosenic SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Biosenic Updates On Current License Agreement With Phebra

May 29 (Reuters) - Bone Therapeutics SA  BIOS.BR :
    * BIOSENIC PROVIDES UPDATE REGARDING CURRENT LICENSE
AGREEMENT
WITH PHEBRA
    * MAINTENANCE OF LICENSE IS NOW SUBJECT TO LAUNCH OF OATO
PHASE
III BEFORE MAY 2024 INSTEAD OF 31 MAY 2023
    * PARTIES ALSO CURRENTLY NEGOTIATING A POTENTIAL
RENEGOTIATION OF
OTHER LICENSING TERMS

Source text for Eikon:  ID:nGNE2kdYtG 
Further company coverage:  BIOS.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Biosenic SA

See all news